Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gentherm (THRM) Accounts Payables (2016 - 2025)

Gentherm (THRM) has 16 years of Accounts Payables data on record, last reported at $260.5 million in Q4 2025.

  • For Q4 2025, Accounts Payables rose 14.85% year-over-year to $260.5 million; the TTM value through Dec 2025 reached $260.5 million, up 14.85%, while the annual FY2025 figure was $260.5 million, 14.85% up from the prior year.
  • Accounts Payables reached $260.5 million in Q4 2025 per THRM's latest filing, down from $263.6 million in the prior quarter.
  • Across five years, Accounts Payables topped out at $263.6 million in Q3 2025 and bottomed at $115.1 million in Q2 2021.
  • Average Accounts Payables over 5 years is $199.2 million, with a median of $211.1 million recorded in 2022.
  • Peak YoY movement for Accounts Payables: surged 75.66% in 2021, then increased 2.65% in 2023.
  • A 5-year view of Accounts Payables shows it stood at $122.7 million in 2021, then surged by 48.48% to $182.2 million in 2022, then grew by 18.44% to $215.8 million in 2023, then grew by 5.09% to $226.8 million in 2024, then rose by 14.85% to $260.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Accounts Payables were $260.5 million in Q4 2025, $263.6 million in Q3 2025, and $254.1 million in Q2 2025.